Join us on June 1st at the Omni Viking Lakes Hotel in Eagan, Minnesota.
The Midwest ACC Women in Cardiology (WIC) Symposium aims to share knowledge and best practices with all clinicians who care for female patients to improve the overall cardiovascular health of women. Physicians, Fellows in Training, CV team members and Poster Contest presenters are welcome to register online.
The Minnesota ACC invites you to attend our inaugural Lipid Journal Club, taking place on Wednesday, May 8th, 2024 from 5:30-8pm at Columbia Golf Course Manor located at 3300 Central Ave NE, Minneapolis, MN 55418.
This meeting will place special emphasis on initiating non-statin medications. The presentation will include research supporting use, case studies, and logistics involved in ordering non-statin medications for hyperlipidemia. We invite all physicians and cardiovascular team members including nurses, nurse practitioners, physician assistants and pharmacists.
AGENDA:
5:30 pm Welcome and Connecting
5:45-6:45 pm Journal article reviews: ORION, FOURIER, CLEAR Trials, and EVKEEZA publications with a case study after each article.
6:45-7:00 pm Indications and insurance coverage for non-statin therapy — When the Stars Align
7:00-7:30 pm Getting the medication to the patient – Prior authorizations to Peer-to-Peer reviews, Health Well Grants
7:30-7:45 pm Q&A, Closing
▪ 2 hours of CME are pending approval for AMA Cat. 1, ACPE, ANCC, AAPA, MOC
▪ Food and Beverages provided. Chowgirls catering: Taco bar with vegan options included
▪ Registration is free but required. Register here.
Please join ACC leaders to learn about the benefits coaching can have in developing your career. Leaders from ACC’s Clinician Well-Being Workgroup and their guests will define how coaching can help with building confidence, improving self-leadership, gaining insights on your skills and increasing well-being. Drs. Jennifer Berliner, Retu Saxena, Dan Murphy, Lee Goldberg, and Sarah Samaan will share their personal experiences with executive coaching, and describe the advantages cardiovascular leaders can gain.
ACC’s Clinician Well-Being Working Group will host Fundamentals in Coaching for Cardiovascular Leaders, January 23, 8 – 9 p.m (EST).
The Center for Advancing Serious Illness Communication (CASIC), a joint initiative of the Minnesota Medical Association (MMA) and Minnesota Hospital Association (MHA), has launched its first series of on-demand training to introduce healthcare providers and other members of care teams to serious illness conversations (SIC).
This three-module introductory training series begins the process of preparing clinicians and healthcare organizations to engage every patient experiencing a serious illness in meaningful discussions about their diagnosis, prognosis and care choices. It focuses on the Serious Illness Communication Guide, an evidence-based tool developed by Ariadne Labs, which is a joint center for health systems innovation at Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health.
The free training is available to all members of care teams who work with patients with serious illnesses. These modules are CME-eligible for physicians.
The newest clinical guideline released by the ACC and the American Heart Association (AHA) provides new and updated recommendations for preventing and optimally managing atrial fibrillation (AFib).
The 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation updates two separate guidelines from 2014 and 2019, respectively, and includes new recommendations addressing AFib and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, AFib catheter or surgical ablation, as well as risk factor modification and prevention.
Among the highlights, are a stronger, more prescriptive focus on healthy lifestyle habits to prevent or lessen the burden of AFib across the disease continuum, including weight loss, physical activity, smoking cessation, alcohol moderation, hypertension and other comorbidities. Use of clinical care pathways, such as nurse-led AFib clinics, is also reasonable, according to the guideline, when it comes to “promoting comprehensive, team-based care and to enhance adherence to evidence-based therapies for AFib and associated conditions.”
The guideline also sets forth a new way to classify AFib, using stages that reinforce the continuum of the disease and underscore the need to use a variety of strategies, including prevention, lifestyle and risk factor modification, screening, and therapy. Additionally, early and more aggressive rhythm control in general is addressed, along with upgraded recommendations for catheter ablation as first-line therapy to prevent disease progression in select patients, including those with heart failure with reduced ejection fraction.
The Midwest Cardiovascular Forum is a 1.5-day conference exploring the latest in cardiology. Sessions include topics for seasoned cardiologists, fellows-in-training, and cardiovascular team members. The 2023 Forum will take place on November 4-5 at the Minneapolis Convention Center in Minneapolis, Minnesota.
Registration rates increase after Wednesday, October 18. Register today to save!
ACC-Minnesota was represented this past week at ACC’s Legislative Conference 2023 in Washington, DC. The three-day meeting offers cardiovascular clinicians spanning the entire care team a chance to hear from ACC leaders, staff and other experts on health policy issues affecting patients and the profession, while also providing an important opportunity to speak directly with members of Congress and their staff.
Congratulations to ACC-MN member Grace Lin, MD, FACC, FASE on being one of six fellows in the 2023-2024 Robert Wood Johnson Foundation Health Policy Fellows Program at the National Academy of Medicine. Great work, Dr. Lin!
Fellows in Training, residents and medical students are invited to participate in the 2023 Midwest Cardiovascular Forum Poster Contest. There will be an award for first, second, and third place in each category. Presenters will be judged on the following criteria: originality, scientific content, presentation and answer to questions raised by the case. Winners will be announced on-site at the 2023 Midwest Cardiovascular Forum.
Contest Eligibility:
Join Us for a Live Interactive CME Webcast!
“Cross-Setting Strategies for Improved Identification, Diagnosis, and Management of Homozygous Hypercholesterolemia” will take place virtually on Wednesday, October 25, 2023 at 6:00 PM CT.
This webcast was organized for the ACC Great Plains, Iowa and Minnesota Chapters.
Homozygous familial hypercholesterolemia (HoFH) is a genetic disorder characterized by markedly elevated levels of low-density lipoprotein cholesterol (LDL-C), leading to premature cardiovascular disease. Affected individuals are typically less responsive or unresponsive to standard lipid-lowering therapies (ie, statins and PCSK9 inhibitors) and may benefit from treatments with alternative mechanisms of action, such as the recently FDA-approved ANGPTL3 inhibitor evinacumab. With this in mind, this program has been designed to educate clinicians about the prevalence of HoFH, the importance of HoFH screening, and the benefits and limitations of current therapies for lipid management in patients with the disease. The nationally recognized expert faculty will also provide practical advice to attendees, based on their personal success, regarding strategies that improve patient access to newer lipid-lowering therapies.
This educational activity has been designed for US cardiologists and internal medicine physicians, nurse practitioners, and physician assistants involved in the identi fication, diagnosis, and management of patients with HoFH.
Integrity Continuing Education, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM.
Mary McGowan, MD
Assistant Professor of Medicine
Geisel School of Medicine at Dartmouth
Lipid Clinic & Lipid Research
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire
